Sex‐dependent molecular landscape of Alzheimer's disease revealed by large‐scale single‐cell transcriptomics
Alzheimer's & Dementia · 2025-02 · 21 (2)
DOI: 10.1002/alz.14476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 31.12.2024. Verfasst von Mohamed Soudy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Data Science Group, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg. Hauptthemen laut MEDLINE: Alzheimer Disease, Transcriptome, Sex Characteristics, Prefrontal Cortex. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Luxembourg Fondation Wivine, Luxembourg National Research Fund, AD-PLCG2.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Alzheimer's disease (AD) shows significant sex differences in prevalence and clinical manifestations, but the underlying molecular mechanisms remain unclear. METHODS This study used a large‐scale, single‐cell transcriptomic atlas of the human prefrontal cortex to investigate sex‐dependent molecular changes in AD. Our approach combined cell type–specific and sex‐specific differential gene expression analysis, pathway enrichment, gene regulatory network construction, and cell–cell communication analysis to identify sex‐dependent changes. RESULTS We found significant sex‐specific gene expression patterns and pathway alterations in AD. Male astrocytes showed changes in cell death pathways, with RPTOR as a key regulator, while female astrocytes had alterations in Wnt signaling and cell cycle regulation. Cell–cell communication analysis uncovered sex‐specific intercellular signaling patterns, with male‐specific impacts on apoptosis‐related signaling and female‐specific alterations in Wnt and calcium signaling. DISCUSSION This study reveals sex‐dependent gene expression patterns, pathway alterations, and intercellular communication changes, suggesting the need for sex‐specific approaches in AD research. Highlights Single‐cell transcriptomics reveals significant sex‐specific molecular signatures in Alzheimer's disease (AD). Male astrocytes show enhanced modulation of apoptotic and cell death pathways in AD; female astrocytes exhibit distinct alterations in Wnt signaling and cell‐cycle regulation. Sex‐dimorphic changes in mitochondrial gene expression are observed in excitatory neurons, suggesting divergent energy metabolism profiles may contribute to AD sex differences. RPTOR is identified as a key regulator of male‐specific changes in astrocytes, implicating the mechanistic target of rapamycin pathway in sex‐dependent AD pathology. New cell–cell communication analyses reveal sex‐specific patterns of intercellular signaling, providing insights into how cellular interactions may differentially contribute to AD pathology in males and females.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Data Science Group, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
ORCID-Profile: Mohamed Soudy, Sophie Le Bars, Enrico Glaab
Förderung
- Luxembourg Fondation Wivine
- Luxembourg National Research Fund
- AD-PLCG2
- RECAST
- PreDYT
Zitieren
APA
Soudy, M., Bars, S. L., & Glaab, E. (2025). Sex‐dependent molecular landscape of Alzheimer's disease revealed by large‐scale single‐cell transcriptomics. Alzheimer's & Dementia, 21(2). https://doi.org/10.1002/alz.14476
Vancouver
Soudy M, Bars SL, Glaab E. Sex‐dependent molecular landscape of Alzheimer's disease revealed by large‐scale single‐cell transcriptomics. Alzheimer's & Dementia. 2025;21(2). doi:10.1002/alz.14476
BibTeX
@article{Soudy2025,
author = {Soudy, Mohamed and Bars, Sophie Le and Glaab, Enrico},
title = {Sex‐dependent molecular landscape of Alzheimer's disease revealed by large‐scale single‐cell transcriptomics},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {2},
doi = {10.1002/alz.14476}
}
EUVIMED